Navigation Links
Experimental antibody shows early promise for treatment of childhood tumor
Date:5/8/2014

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody produced at St. Jude Children's Research Hospital. Four patients are still alive after more than two-and-a-half years and without additional treatment.

Findings from the Phase I study were published recently online and will appear in the May 10 edition of the Journal of Clinical Oncology. The results prompted St. Jude to expand clinical trials of the monoclonal antibody hu14.18K322A to include patients newly diagnosed with neuroblastoma. Monoclonal antibodies are engineered in the laboratory to recognize and attach to specific markers carried on the cell surface.

Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers. While certain patients, particularly infants, enjoy cure rates of 90 percent or better, the outlook is worse for high-risk patients, including those whose disease has spread widely. New treatments are urgently needed for these patients, less than half of whom currently enjoy long-term, disease-free survival.

"This was the first time this experimental antibody was tried in patients. We were encouraged with the response," said first and corresponding author Fariba Navid, M.D., an associate member of the St. Jude Department of Oncology. "The percentage of patients who benefited from treatment with hu14.18K322A was unusual for a Phase I study."

Phase I studies focus on questions related to the safety and best dose of experimental therapies. The research involves patient volunteers whose cancer has returned or did not respond to standard treatment, which for neuroblastoma includes surgery, chemotherapy, radiation and bone marrow transplants.

In this study, 38 St. Jude patients received one of nine different
'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Experimental drug prolongs life span in mice
2. Experimental drug shows promise for treatment-resistant leukemias
3. Diabetes drug shows promise in reducing Alzheimers disease in an experimental model
4. Experimental drug could enhance multiple myeloma and myeloid leukemia therapies
5. Experimental drug shows encouraging results in treating most common form of lung cancer
6. Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant
7. ASSURE study of experimental agent to raise HDL yields disappointing and surprising results
8. York physicists offer novel insight into experimental cancer treatment
9. Experimental Drug Shows Benefits Against Melanoma in Early Study
10. Experimental Drugs Show Promise Against Prostate Cancer
11. Experimental Drug Seems to Aid Memory in Mice With Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 05, 2015 Don’t have time ... for a fitness membership? Don’t know which workout equipment ... obstacles in order to help members achieve their heath ... Streaming Fitness, an educational, caused-based wellness company, today announces ... streaming fitness classes led by certified trainers, nutritional information ...
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 Major ... 2012, with the belief that ultimate Frisbee™ is home ... the next sport that engages the world. Nike Ultimate ... level, by creating opportunities for young athletes to learn ... collaboration with MLU the perfect fit. , The Nike ...
(Date:5/5/2015)... 05, 2015 Igantia , an ... leads an international initiative to examine key biological milestones ... human lifespan. Scientists at Igantia believe that better ... the initiation of her menstrual cycle to her transition ... aging and, ultimately, extend the lifespan. , By ...
(Date:5/5/2015)... After record-breaking sales of Extend Nutrition’s ... Cookies & Cream flavor at stores nationwide this month. ... raised the bar for nutritional snacks. The brand ... nutritional profile, backed by international patents and clinical studies. ... additional new products and expand retail availability throughout 2015. ...
(Date:5/5/2015)... 2015 B. E. Smith, the only ... has been retained to recruit a new administrator ... top executive search firm in the healthcare industry, B. ... executives into organizations. , Shodair Children’s Hospital is the ... to offer both acute and residential inpatient services, as ...
Breaking Medicine News(10 mins):Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 3Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:Shodair Children’s Hospital Retains B. E. Smith to Recruit New Administrator 2Health News:Shodair Children’s Hospital Retains B. E. Smith to Recruit New Administrator 3
... (June 24, 2008) The American Academy of Cosmetic Surgery ... women their opinions on medical spas. Findings revealed that ... customers of these facilities. Yet half of those women ... facility. , Women ages 18-34 were more than three ...
... Further Royal, Brompton and Harefield NHS Trust,s Leadership Role ... ... June 24 Stereotaxis, Inc. (Nasdaq:,STXS) announced that British Prime Minister ... the art electrophysiology lab at,Royal Brompton Hospital in London. The new ...
... (NYSE:,HRC) today announced the signing of a distribution ... agreement will enhance selling,efforts for Hill-Rom,s product The ... care facilities within the United States., "We ... said Kim,Dennis, group vice president, Post Acute Care ...
... Ernst & Young Report Reveals Healthcare CFO Perspectives on Top Industry ... ... With the US healthcare system on the,threshold of change, healthcare chief financial ... transformation before,the arrival of any public policy mandates. CFOs face daunting challenges,and ...
... Enterprises Ltd.,("Beeston" or the "Company") (OTC-BB: BESE) announces ... that it holds under option from,Candorado Operating Company ... the northern border of G W R Resources ... copper-gold deposits., The Company is carrying out ...
... drinking in the young is a "fashion phenomenon" where drinkers ... , A study conducted at Durham University,s Institute of Advanced ... a key factor in the spread of the rapid consumption ... is blamed for serious anti-social and criminal behaviour. , ...
Cached Medicine News:Health News:London's Royal Brompton Hospital Opens New Electrophysiology Lab With State of the Art Magnetic Technology to Treat Arrhythmias 2Health News:London's Royal Brompton Hospital Opens New Electrophysiology Lab With State of the Art Magnetic Technology to Treat Arrhythmias 3Health News:Hill-Rom Announces Agreement With Tri-anim to Enhance Distribution Channels for The Vest(R) System in U.S. Hospitals & Long-Term Care Facilities 2Health News:Hill-Rom Announces Agreement With Tri-anim to Enhance Distribution Channels for The Vest(R) System in U.S. Hospitals & Long-Term Care Facilities 3Health News:Hill-Rom Announces Agreement With Tri-anim to Enhance Distribution Channels for The Vest(R) System in U.S. Hospitals & Long-Term Care Facilities 4Health News:Intersection of Financial and Regulatory Forces is Broadening Roles of Healthcare CFOs 2Health News:Intersection of Financial and Regulatory Forces is Broadening Roles of Healthcare CFOs 3Health News:Beeston completes drilling on Bluff Lake property, 100 Mile House 2Health News:Binge drinking due to 'copying' behavior 2
(Date:5/5/2015)... , May 5, 2015 ... or the "Company"), a premier provider of innovative medical ... today issued an update to shareholders and the investment ... financing and acquisition of the proprietary Bioelectrical Signal Therapy™ ... completion of its S-1, as well as its plans ...
(Date:5/5/2015)... May 05, 2015 Research and Markets ... of the "Clinical Laboratory,Molecular Diagnostics and Genomic ... 2019 - Asia Pacific Version" report to ... keeps on growing. Clinical laboratory testing is positioned ... especially genomics. A range of dynamic trends are ...
(Date:5/5/2015)... , May 5, 2015  The Association of ... of Recognition™ to The Preoperative Stop and Go ... Ph.D. and Mauricio Gonzalez , M.D., anesthesia providers ... Preoperative Stop and Go Sign product is distributed by ... anesthesia management company, and is in compliance with the ...
Breaking Medicine Technology:E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 2E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 4E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 5Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Report 2015-2019 2The Preoperative Stop and Go Sign Interactive Checklist Awarded AORN Seal of Recognition 2The Preoperative Stop and Go Sign Interactive Checklist Awarded AORN Seal of Recognition 3
... Inc. (CMP.ASX) today announced its new Somte® PSG portable ... new study to further investigate the link between sleep ... populations.  Somte® PSG was chosen because of its ability ... with acceptable participant burden, according to Dr. Susan Redline, ...
... Decision Resources, one of the world,s leading research ... that Boehringer Ingelheim/Pfizer,s Spiriva will most likely strengthen its ... chronic obstructive pulmonary disease (COPD) through greater use in ... the sales leaders in the COPD market, and hold ...
Cached Medicine Technology:Compumedics Home Sleep Testing System Selected for Use in US National Institute of Health (NIH)-Sponsored Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study 2Compumedics Home Sleep Testing System Selected for Use in US National Institute of Health (NIH)-Sponsored Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study 3Compumedics Home Sleep Testing System Selected for Use in US National Institute of Health (NIH)-Sponsored Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study 4In the Treatment of COPD, Greater Use in the Primary Care Setting Will Strengthen Spiriva's Position Among Sales Leaders 2In the Treatment of COPD, Greater Use in the Primary Care Setting Will Strengthen Spiriva's Position Among Sales Leaders 3
... image guided surgery system offers full-featured ... design and use. It provides unparalleled ... localize critical anatomy and plan optimal ... surgeons an easy-to-use, technologically advanced approach ...
Assists in early recognition of changes in the macula and foveal areas., ,Only 6 patient responses required for diagnosis of functional disturbances, from small scotoma to distortions. Full instructi...
... Clips have become a required ... ,These useful and inexpensive clips ... patient's spectacle frame. Each cell ... and the rubber coating on ...
Designed for young and disabled children but equally suitable for older children and adults., ,Optional 6/60 to 6/24 booklet available for patients who fail standard screening test and require fu...
Medicine Products: